---
annotations:
- id: PW:0000926
  parent: regulatory pathway
  type: Pathway Ontology
  value: pro-inflammatory cytokine mediated pathway
authors:
- RaatsS
- Ariajadhav
- Marvin M2
- Duygudd
- Eweitz
citedin:
- link: PMC9377275
  title: 'Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug
    and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics
    and System Biology Analyses: The Role of Pregnane X Receptor (2022)'
- link: 10.1016/j.bbrep.2023.101602
  title: Statistical and network analyses reveal mechanisms for the enhancement of
    macrophage immunity by manganese in Mycobacterium tuberculosis infection (2024)
- link: PMC12034122
  title: Characterization and comparative profiling of piRNAs in serum biopsies of
    pediatric Wilms tumor patients (2025)
communities: []
description: Inflammatory cytokines leading to cytokine storm after NF-kappa-B and
  prostaglandin activation. KEGG pathway 05171 and a paper by Robb et al. was referenced
  for the pathway development.
last-edited: 2024-02-21
ndex: daaaa23d-5c74-11ec-b3be-0ac135e8bacf
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP5095
- /instance/WP5095
- /instance/WP5095_r128722
revision: r128722
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP5095.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Inflammatory cytokines leading to cytokine storm after NF-kappa-B and
    prostaglandin activation. KEGG pathway 05171 and a paper by Robb et al. was referenced
    for the pathway development.
  keywords:
  - AREG
  - CCL1
  - CCL11
  - CCL13
  - CCL14
  - CCL15
  - CCL16
  - CCL17
  - CCL18
  - CCL19
  - CCL2
  - CCL20
  - CCL21
  - CCL22
  - CCL23
  - CCL24
  - CCL25
  - CCL26
  - CCL27
  - CCL28
  - CCL3
  - CCL3L3
  - CCL4
  - CCL4L2
  - CCL5
  - CCL7
  - CCL8
  - CNTF
  - CSF1
  - CSF2
  - CSF3
  - CTF1
  - CX3CL1
  - CXCL1
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL16
  - CXCL17
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - CXCL9
  - EBI3
  - EPO
  - IFNA1
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA2
  - IFNA21
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNB1
  - IFNG
  - IFNK
  - IFNL1
  - IFNL2
  - IFNL3
  - IFNW1
  - IL-12
  - IL-1B
  - IL-6
  - IL-8
  - IL10
  - IL11
  - IL12A
  - IL12B
  - IL13
  - IL15
  - IL17A
  - IL17B
  - IL17C
  - IL17D
  - IL17F
  - IL18
  - IL19
  - IL1A
  - IL1B
  - IL1F10
  - IL1RN
  - IL2
  - IL20
  - IL21
  - IL22
  - IL23A
  - IL24
  - IL25
  - IL26
  - IL27
  - IL3
  - IL31
  - IL33
  - IL36A
  - IL36B
  - IL36G
  - IL36RN
  - IL37
  - IL4
  - IL5
  - IL6
  - IL7
  - IL9
  - LIF
  - Lymphotoxin-alpha
  - MMP1
  - MMP3
  - MMP9
  - 'NF-kappa-B  '
  - OSM
  - PF4
  - PF4V1
  - PPBP
  - Prostaglandin E2
  - Prostaglandin I2
  - ROS
  - SPP1
  - TGFB1
  - TNF
  - TNFSF13
  - TNFSF13B
  - TSLP
  - VEGFA
  - XCL1
  - XCL2
  license: CC0
  name: Overview of proinflammatory and profibrotic mediators
seo: CreativeWork
title: Overview of proinflammatory and profibrotic mediators
wpid: WP5095
---